Philadelphia, PA, United States of America

Yoshio Hojima


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2000-2003

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Yoshio Hojima

Introduction

Yoshio Hojima is a notable inventor based in Philadelphia, PA, contributing significantly to the field of biotechnology. With a total of three patents to his name, Hojima has made remarkable strides in the understanding and application of protein-based innovations.

Latest Patents

Hojima's recent endeavors include two patents for "Recombinant C-proteinase and processes, methods and uses thereof." These innovative inventions focus on the isolation and identification of the nucleic acid sequence encoding C-proteinase. The patents detail the recognition of the protein's activity, applications, and relevant tools and methods for its use. This work represents a pivotal advancement in molecular biology and its applications in various scientific fields.

Career Highlights

Throughout his career, Yoshio Hojima has collaborated with esteemed institutions, notably Thomas Jefferson University and Fibrogen, Inc. His work in these organizations has allowed him to apply his research findings practically, enhancing the academic and medical communities' understanding of protein interactions and their implications.

Collaborations

Hojima has worked alongside distinguished colleagues such as Darwin J Prockop and Shi-Wu Li. These collaborations have further enriched his research experiences, fostering innovative developments that have the potential to impact various areas within biotechnology.

Conclusion

Yoshio Hojima's inventive contributions continue to shape the landscape of biological research. His patents not only underscore his impressive expertise but also indicate the ongoing importance of innovation in the study of proteins and their functional roles. As he expands his work in the field, Hojima remains a valuable asset to both his institutions and the broader scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…